Efficacy of Two Nasal Products Based on Diluted Seawater in the Treatment of Upper Respiratory Infections/Conditions

Exclusion Criteria

• •Person not showing cold symptoms, particularly no nasal congestion (chronic dry rhinitis, or Jackson derived score (nasal congestion + nasal discharge) \< 4 on Day 0).
• •Person undergoing treatment with a cortisone derivative, mucolytic, or medication containing pseudoephedrine or a similar product acting on nasal congestion or having used such a product within the 3 days preceding inclusion.
• •Person having used a nasal wash product within the 3 days preceding inclusion.
• •Person whose ability to use the product daily and complete the daily follow-up diary is in doubt.
• •Person refusing to sign the informed consent form prior to the study.
• •Person participating or having participated in any other clinical study within the 30 days preceding the study.
• •Person participating in any other clinical study.